• NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance Stocktwits Fri, 03 Jul 2026 14:42:25 GMT
• InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026 TradingView Thu, 02 Jul 2026 21:03:01 GMT
• Board member Raymond Cohen to leave InspireMD (NSPR) effective July 1, 2026 Stock Titan Thu, 02 Jul 2026 21:02:24 GMT
• Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $4 Moomoo Mon, 29 Jun 2026 23:17:54 GMT
• inspiremd, inc.(nasdaqcm: nspr) dropped from russell 3000e growth benchmark marketscreener.com Mon, 29 Jun 2026 05:14:02 GMT
• nspr rallies after hours on fda green light for key stroke-prevention trial despite withdrawn annual guidance Stocktwits Sun, 28 Jun 2026 23:14:29 GMT
• InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell Microcap Growth Benchmark Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• inspiremd issues voluntary recalls for cguard prime device in us MSN Fri, 26 Jun 2026 17:21:00 GMT
• enterprise value to ebitda forward of inspiremd inc. – nasdaq:nspr TradingView Thu, 25 Jun 2026 20:04:25 GMT
• enterprise value to revenue forward of inspiremd inc. – nasdaq:nspr TradingView Thu, 25 Jun 2026 19:14:23 GMT
• inspiremd inc (nspr) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• inspiremd issues voluntary recalls for cguard prime device in us MSN Wed, 24 Jun 2026 12:55:28 GMT
• nspr q1 2026 earnings: narrower-than-expected loss highlights cost discipline - forward guidance trends dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• inspiremd inc (nspr) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• nspr rallies after hours on fda green light for key stroke-prevention trial despite withdrawn annual guidance Stocktwits Sun, 21 Jun 2026 05:13:13 GMT
• cguardians ii shows positive 30-day outcomes for carotid stent use in tcar procedures Vascular News Fri, 19 Jun 2026 13:38:28 GMT
• InspireMD, Inc. Announces Recalling of Cguard Prime Carotid Stent System 135Cm, 8Mmx30mm marketscreener.com Fri, 19 Jun 2026 07:00:00 GMT
• inspiremd inc (nspr) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 11:23:08 GMT
• inspiremd inc (nspr) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:06:40 GMT
• inspiremd inc (nspr) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:05:08 GMT
• inspiremd inc (nspr) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 10:52:31 GMT
• inspiremd inc (nspr) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 10:51:51 GMT
• inspiremd inc (nspr) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 10:50:36 GMT
• inspiremd inc (nspr) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 10:48:34 GMT
• inspiremd inc (nspr) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 10:48:33 GMT
• inspiremd inc. (nspr) gains momentum: breaking above key support - market leader picks dars.gov.et Wed, 17 Jun 2026 07:00:00 GMT
• InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• inspiremd announces inducement grants under nasdaq listing rule 5635(4) marketscreener.com Mon, 15 Jun 2026 07:00:00 GMT
• inspiremd announces inducement grants under nasdaq listing rule 5635(c)(4) The Manila Times Sat, 13 Jun 2026 07:00:00 GMT
• inspiremd announces inducement grants under nasdaq listing rule 5635(c)(4) The Manila Times Fri, 12 Jun 2026 20:11:55 GMT
• Six new InspireMD employees receive 91,161-share stock grants Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• NSPR Q1 2026 Earnings: EPS Beat Surprises on Strong Cost Management - Guidance Update dars.gov.et Fri, 12 Jun 2026 07:00:00 GMT
• Stroke-prevention stent hits 100% success in 50 high-risk patients Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• inspiremd announces 30-day results from the cguardians ii clinical trial of the cguard prime 80 cm implant for use in tcar procedu... The Manila Times Thu, 11 Jun 2026 07:00:00 GMT
• inspiremd (nspr) reports 100% device success in tcar trial Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use ... GlobeNewswire Mon, 08 Jun 2026 07:00:00 GMT
• First patient enrolled in InspireMD's CGUARDIANS III pivotal study of neuro protection system for TCAR Vascular News Mon, 08 Jun 2026 07:00:00 GMT
• nspr q1 2026 earnings: eps surprises to the upside amid limited revenue visibility - financial data dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• nspr technical analysis | trend, signals & chart patterns | inspiremd inc (nasdaq:nspr) ChartMill Thu, 04 Jun 2026 07:00:00 GMT
• inspiremd (nspr) holders ok 250m authorized shares, re-elect directors Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• nspr technical analysis | trend, signals & chart patterns | inspiremd inc (nasdaq:nspr) ChartMill Wed, 03 Jun 2026 07:00:00 GMT
• inspiremd director paul stuka buys $17,500 in shares by investing.com Investing.com Australia Sat, 30 May 2026 07:00:00 GMT
• director paul stuka buys 20,000 inspiremd (nspr) shares in open-market trade Stock Titan Fri, 29 May 2026 07:00:00 GMT
• inspiremd anticipates fda approval of original cguard delivery system in q3 2026 as it withdraws 2026 revenue guidance MSN Thu, 28 May 2026 09:34:55 GMT
• inspiremd issues voluntary recalls for cguard prime device in us MSN Thu, 28 May 2026 09:10:08 GMT
• InspireMD Inc. (NSPR) Q1 2026 Earnings: Narrower Loss Than Expected But Shares Slide - Pre-Earnings Setup dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• InspireMD (NSPR) Slides 6.5% – Support Levels in Focus as Biotechnology Stock Struggles - Fade Trade dars.gov.et Tue, 26 May 2026 07:00:00 GMT
• InspireMD (NSPR) Q1 2026 Earnings: EPS Beat Despite Net Loss, Shares Dip 2.9% - Return On Capital Město Břeclav Sat, 23 May 2026 07:00:00 GMT
• Paul Stuka to Retire from InspireMD Board, Will Not Seek Re‑election TradingView Fri, 22 May 2026 07:00:00 GMT
• inspiremd (nspr) chair paul stuka plans board retirement in 2027 Stock Titan Fri, 22 May 2026 07:00:00 GMT
• inspiremd cco shane gleason sells $189,594 in stock by investing.com Investing.com Australia Fri, 22 May 2026 07:00:00 GMT
• nspr technical analysis | trend, signals & chart patterns | inspiremd inc (nasdaq:nspr) ChartMill Fri, 22 May 2026 07:00:00 GMT
• inspiremd (nspr) q1 2026 earnings surprise: eps $-0.16, up significant - trending buy opportunities Newser Thu, 21 May 2026 14:46:32 GMT
• inspiremd (nspr) cco auto-sells shares to cover rsu tax obligations Stock Titan Thu, 21 May 2026 07:00:00 GMT
• nspr rallies after hours on fda green light for key stroke-prevention trial despite withdrawn annual guidance MSN Sun, 17 May 2026 10:30:07 GMT
• nspr rallies after hours on fda green light for key stroke-prevention trial despite withdrawn annual guidance MSN Sat, 16 May 2026 05:41:06 GMT
• inspiremd insider makes bold move with fresh share purchase TipRanks Sat, 16 May 2026 03:49:16 GMT
• Director Stuka increases InspireMD (NSPR) stake with 15,000-share buys Stock Titan Fri, 15 May 2026 07:00:00 GMT
• nantahala reports 4.82m shares in inspiremd (nspr) including convertibles Stock Titan Fri, 15 May 2026 07:00:00 GMT
• velan capital holds 4.99% of inspiremd (nasdaq: nspr) via 2.35m shares Stock Titan Fri, 15 May 2026 07:00:00 GMT
• nspr stock price, quote & chart | inspiremd inc (nasdaq:nspr) ChartMill Fri, 15 May 2026 07:00:00 GMT
• nspr technical analysis | trend, signals & chart patterns | inspiremd inc (nasdaq:nspr) ChartMill Fri, 15 May 2026 07:00:00 GMT
• inspiremd ceo marvin slosman buys $25,200 in company stock by investing.com Investing.com Australia Thu, 14 May 2026 07:00:00 GMT
• top executive makes bold move with fresh inspiremd stock purchase TipRanks Thu, 14 May 2026 02:41:55 GMT
• inspiremd inc (nspr) ceo marvin slosman increases stake with rec GuruFocus Thu, 14 May 2026 01:31:00 GMT
• nspr: endovascular stenting for carotid disease is accelerating, backed by best-in-class clinical results TradingView Wed, 13 May 2026 23:54:19 GMT
• InspireMD (NSPR) CEO adds 21,000 shares in $1.20 open-market buy Stock Titan Wed, 13 May 2026 07:00:00 GMT
• inspiremd ceo marvin slosman buys $25,200 in company stock Investing.com Wed, 13 May 2026 07:00:00 GMT
• inspiremd (nspr) director boosts stake with 75,626-share buy, corrects 10b5-1 and ownership details Stock Titan Wed, 13 May 2026 07:00:00 GMT
• inspiremd director paul stuka buys $88,026 in shares by investing.com Investing.com Nigeria Wed, 13 May 2026 07:00:00 GMT
• inspiremd insider makes bold new bet on the company’s future TipRanks Wed, 13 May 2026 02:09:22 GMT
• inspiremd (nspr) director paul stuka adds 75,626 shares in open-market buys Stock Titan Tue, 12 May 2026 07:00:00 GMT
• inspiremd insider makes bold new bet on the company’s future TipRanks Tue, 12 May 2026 07:00:00 GMT
• nspr rallies after hours on fda green light for key stroke-prevention trial despite withdrawn annual guidance MSN Mon, 11 May 2026 12:50:51 GMT
• Why Medical Device Recalls Like InspireMD's Can Be a Good Thing Medical Device and Diagnostic industry Mon, 11 May 2026 07:00:00 GMT
• inspiremd director ward r. buys $102,637 in company stock by investing.com Investing.com Australia Sat, 09 May 2026 07:00:00 GMT
• insiders make bold moves as inspiremd directors load up on shares TipRanks Sat, 09 May 2026 02:27:06 GMT
• inspiremd director gary roubin buys $106,200 in company stock Investing.com Fri, 08 May 2026 07:00:00 GMT
• director boosts inspiremd (nspr) stake with 90,000-share buy Stock Titan Fri, 08 May 2026 07:00:00 GMT
• director paul stuka adds 7,895 inspiremd (nspr) shares in open‑market buys Stock Titan Fri, 08 May 2026 07:00:00 GMT
• inspiremd director ward r. buys $102,637 in company stock Investing.com Fri, 08 May 2026 07:00:00 GMT
• insider buying: inspiremd (nyse:nspr) director acquires 15,995 shares of stock MarketBeat Fri, 08 May 2026 07:00:00 GMT
• gary roubin buys 90,000 shares of inspiremd (nyse:nspr) stock MarketBeat Fri, 08 May 2026 07:00:00 GMT
• insiders make bold moves as inspiremd directors load up on shares TipRanks Fri, 08 May 2026 07:00:00 GMT
• nspr rallies after hours on fda green light for key stroke-prevention trial despite withdrawn annual guidance MSN Fri, 08 May 2026 03:37:07 GMT
• inspiremd, inc. 1q 2026: revenue $3.4m, eps $(0.16) — 10-q summary TradingView Thu, 07 May 2026 13:01:01 GMT
• inspiremd initiates voluntary us recall of cguard prime 135cm carotid stent delivery system NeuroNews International Thu, 07 May 2026 07:00:00 GMT
• analysts’ opinions are mixed on these healthcare stocks: brightspring health services, inc. (btsg), pfizer (pfe) and inspiremd (ns... The Globe and Mail Thu, 07 May 2026 07:00:00 GMT
• director paul stuka adds 7,895 inspiremd (nspr) shares in open‑market buys Stock Titan Thu, 07 May 2026 07:00:00 GMT
• inspiremd (nasdaq: nspr) q1 2026 growth, recall and going concern Stock Titan Thu, 07 May 2026 07:00:00 GMT
• Stroke device maker InspireMD to webcast May 13 conference talk Stock Titan Wed, 06 May 2026 07:00:00 GMT
• inspiremd to participate in upcoming bank of america securities 2026 global healthcare conference marketscreener.com Wed, 06 May 2026 07:00:00 GMT
• maxim group maintains inspiremd(nspr.us) with buy rating, cuts target price to $4 Moomoo Wed, 06 May 2026 07:00:00 GMT
• inspiremd to present at bank of america 2026 global healthcare conference on may 13 Pluang Wed, 06 May 2026 07:00:00 GMT
• inspiremd, inc. (nasdaq:nspr) q1 2026 earnings call transcript Insider Monkey Wed, 06 May 2026 07:00:00 GMT
• inspiremd issues voluntary recalls for cguard prime device in us Medical Device Network Tue, 05 May 2026 10:17:56 GMT
• nspr rallies after hours on fda green light for key stroke-prevention trial despite withdrawn annual guidance MSN Tue, 05 May 2026 09:47:26 GMT
• us fda approves inspiremd’s ide application for cguardians iii pivotal study Vascular News Tue, 05 May 2026 09:04:02 GMT
• InspireMD initiates voluntary US recall of CGuard Prime 135cm carotid stent delivery system Vascular News Tue, 05 May 2026 07:00:00 GMT
• InspireMD announces US FDA approval of IDE application for CGUARDIANS III pivotal study NeuroNews International Tue, 05 May 2026 07:00:00 GMT
• InspireMD Recalls CGuard Prime Stent Delivery System, Withdraws 2026 Guidance Medical Device and Diagnostic industry Tue, 05 May 2026 07:00:00 GMT
• InspireMD Reports First Quarter 2026 Financial Results The Manila Times Tue, 05 May 2026 07:00:00 GMT
• lake street maintains inspiremd(nspr.us) with buy rating, maintains target price $4 Moomoo Tue, 05 May 2026 07:00:00 GMT
• piper sandler initiates inspiremd(nspr.us) with buy rating, announces target price $3 Moomoo Tue, 05 May 2026 07:00:00 GMT
• inspiremd price target lowered to $3 from $4 at piper sandler TipRanks Tue, 05 May 2026 07:00:00 GMT
• inspiremd anticipates fda approval of original cguard delivery system in q3 2026 as it withdraws 2026 revenue guidance MSN Tue, 05 May 2026 04:09:08 GMT
• nspr: cguard® prime leverages clinical leadership and innovation to capture a growing carotid stenting market TradingView Mon, 04 May 2026 23:35:16 GMT
• nspr: q1 revenue up 122% year-over-year; u.s. relaunch expected after fda approval in q3 2026 TradingView Mon, 04 May 2026 21:43:46 GMT
• inspiremd (nasdaq:nspr) q1 beat fails to impress as stock slides ChartMill Mon, 04 May 2026 21:34:01 GMT
• inspiremd inc reports results for the quarter ended march 31 - earnings summary TradingView Mon, 04 May 2026 21:02:30 GMT
• InspireMD issues voluntary recalls for CGuard Prime device in US Medical Device Network Mon, 04 May 2026 07:00:00 GMT
• InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates Yahoo Finance Mon, 04 May 2026 07:00:00 GMT
• Earnings call transcript: InspireMD beats Q1 2026 forecasts but faces operational pause Investing.com Mon, 04 May 2026 07:00:00 GMT
InspireMD, Inc(NASDAQ:NSPR) 
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention ...
Website: http://www.inspiremd.com
Founded: 2005
Full Time Employees: 48
Sector: Healthcare
Industry: Medical Devices